A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a dangerous brain tumor known for its quick growth and resistance to conventional treatments. Studies are constantly underway to identify new therapeutic strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for glioblastoma treatment. LCA168 is a protein that is abundantly produced in GBM cells